Hadi Hamishehkar

Hadi Hamishehkar

Auto-generated profile, based on publicly available information

Hadi Hamishehkar

Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2016 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
HHHadi Hamishehkar
Hadi Hamishehkar
FRFarhad Ranjdoost
Farhad Ranjdoost
PAparina asgharian
parina asgharian
AMAta Mahmoodpoor
Ata Mahmoodpoor
SSSarvin Sanaie
Sarvin Sanaie
The consumption of a daily multivitamin among people all over the world is dramatically increasing in recent years. Most of the people believe that if vitamins are not effective, at least they are safe. However, the long term health consequences of vitamins consumption are unknown. This study aimed to assess the side effects and possible harmful and detrimental properties of vitamins and to discuss whether vitamins can be used as safe health products or dietary supplements. We performed a MEDLINE/PubMed, EMBASE, Scopus and Google Scholar search and assessed reference lists of the included studies which were published from 1993 through 2015. The studies, with an emphasis on RCTs (randomized controlled clinical trials), were reviewed. As some vitamins such as fat-soluble vitamins (vitamin A, vitamin D, vitamin E), and also some of the water-soluble vitamins like folic acid may cause adverse events and some like vitamin C is widely taken assuming that it has so many benefits and no harm, we included relevant studies with negative or undesired results regarding the effect of these vitamins on health. Our recommendation is that taking high-dose supplements of vitamins A, E, D, C, and folic acid is not always effective for prevention of disease, and it can even be harmful to the health.

21 September 2015 in The Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
TETaher Entezari-Maleki
Taher Entezari-Maleki
SDSamaneh Dousti
Samaneh Dousti
HHHadi Hamishehkar
Hadi Hamishehkar
KGKheirollah Gholami
Kheirollah Gholami


20 April 2023 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
AMAta Mahmoodpoor
Ata Mahmoodpoor
SSSarvin Sanaie
Sarvin Sanaie
TSTohid Sarfaraz
Tohid Sarfaraz
KSKamran Shadvar
Kamran Shadvar
VFVahid Fattahi
Vahid Fattahi
FRFarshid Rahimi-Bashar
Farshid Rahimi-Bashar
Purpose: Modified Nutrition Risk in the Critically Ill (NUTRIC) score (mNUTRIC score) have been validated as screening tool for quantifying risk of adverse outcome critically ill patients admitted to the intensive care units (ICUs). The aim of this study was to evaluate the prognostic value of mNUTRIC score to assess outcomes in this population. Materials and methods: This prospective, observational study was conducted on adult patients admitted to the general ICUs of two university affiliated hospital in northwest of Iran. The association between the mNUTRIC score and outcomes was assessed using the univariate and multivariate binary logistic regression. The performance of mNUTRIC score to predict outcomes was assessed using the receiver operating characteristic (ROC)-curve. Results: In total 445 ICU patients were enrolled. Based on mNUTRIC score, 62 (13.9%) and 383 (86.1%) individuals were identified at high and low nutritional risk, respectively. The area under the curve (AUC) for predicting ICU mortality, using vasopressor, duration of vasopressor, and mechanical ventilation (MV) duration were (AUC: 0.973, 95% CI: 0.954–0.986, P < 0.001), (AUC: 0.807, 95% CI: 0.767–0.843, P < 0.001), (AUC: 0.726, 95% CI: 0.680–0.769, P < 0.001) and (AUC: 0.710, 95% CI: 0.666–0.752, P < 0.001), respectively. Conclusions: An excellent and good predictive performance of the mNUTRIC score was found regarding ICU mortality and using vasopressor, respectively. However, this predictive was fair for MV and vasopressor duration and poor for ICU and hospital length of stay.

31 January 2016 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
AMAta Mahmoodpoor
Ata Mahmoodpoor
HHHadi Hamishehkar
Hadi Hamishehkar
MBMahammadtaghi Beigmohammadi
Mahammadtaghi Beigmohammadi
SSSarvin Sanaie
Sarvin Sanaie
KSKamran Shadvar
Kamran Shadvar
SSSaeid Safari
Saeid Safari
Background: Hypoglycemia is a common and the most important complication of intensive insulin therapy in critically ill patients. Because of hypoglycemia’s impact on the cardinal organs as a fuel, if untreated it could results in permanent brain damage and increased mortality. Objectives: In this study, we aim to evaluate the incidence of hypoglycemia, its risk factors, and its relationship with mortality in critically ill patients. Patients and Methods: Five hundred adult patients who admitted to an intensive care unit (ICU) were enrolled in this study. A program of glycemic control with a target of 100 - 140 mg/dL was instituted. We used the threshold of 150 mg/dL for septic patients, which were monitored by point of care devices for capillary blood measurement. We detected hypoglycemia with a blood sugar of less than 50 mg/dL and with the detection of each episode of hypoglycemia, blood glucose measurement was performed every 30 minutes. Results: Five hundred patients experienced at least one episode of hypoglycemia, almost always on the third day. Of 15 expired patients who had one hypoglycemia episode, the most common causes were multiple trauma and sepsis. Increases in the sequential organ failure assessment (SOFA) number augmented the hypoglycemia risk to 52% (P < 0.001). Moreover, in patients with acute kidney injury (AKI), the risk of hypoglycemia is 10 times greater than in those without AKI (RR: 10.3, CI: 3.16 - 33.6, P < 0.001). ICU admission blood sugar has a significant relationship with mortality (RR: 1.01, CI: 1.004 - 1.02, P < 0.006). Hypoglycemia increased the mortality rate twofold, but it was not significant (RR: 1.2, CI: 0.927 - 1.58, P = 0.221). Conclusions: Our results showed that the SOFA score, AKI, and hemoglobin A1c are the independent risk factors for the development of hypoglycemia and demonstrated that ICU admission blood glucose, Hba1c, and hypoglycemia increased the risk of death, but only ICU admission blood glucose is significantly related to increased mortality. Keywords: Hypoglycemia; Risk Factors; Mortality; Intensive Care Unit

19 June 2018 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
AMAta Mahmoodpoor
Ata Mahmoodpoor
MMMahsa Medghalchi
Mahsa Medghalchi
HNHossein Nazemiyeh
Hossein Nazemiyeh
PAParina Asgharian
Parina Asgharian
KSKamran Shadvar
Kamran Shadvar
HHHadi Hamishehkar
Hadi Hamishehkar
Purpose: Cucurbita maxima Duchense (C. maxima) has been widely used in China and Mexico as a hypoglycemic plant for controlling blood glucose in diabetic patients. Furthermore, in northwest of Iran, this plant is used traditionally for controlling of diabetes. We examined the effect of C. maxima pulp besides insulin on control of hyperglycemia in diabetic patients admitted to Intensive care unit (ICU). Methods: Twenty critically ill patients who were admitted to the ICU were enrolled in this study. 5g lyophilized powder of C. maxima was administrated every 12 hours for 3 days. Moreover, blood glucose level and insulin dose were measured every 1-4 hours during 3 days before administration and 3days at the time of C. maxima administration. Results: The average of glucose level in 3 days before C. maxima administration was 214.9 ± 55.7 mg/dl, while in 3 days during C. maxima administration it was decreased to 178.4 ± 36.1 mg/dl (P<0.001). Additionally, the average insulin dose during 3 days before intervention was 48.05 ± 36.5 IU and during the 3 days of C. maxima administration was decreased to 39.5 ± 27.8 IU (P=0.06). Conclusion: It seems that C. maxima may decrease high blood glucose level fast and effective in diabetic critically ill patients.